Glioblastoma Clinical Trials in Rochester, Minnesota
11 recruitingRochester, Minnesota
Showing 1–11 of 11 trials
Recruiting
Phase 3
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
Glioblastoma
NovoCure GmbH741 enrolled82 locationsNCT06556563
Recruiting
Early Phase 1
Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma
Recurrent GlioblastomaProgressive Glioblastoma
Mayo Clinic8 enrolled1 locationNCT07076472
Recruiting
Not Applicable
Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
Metastatic Malignant Neoplasm in the BrainGlioblastomaGlioma
Mayo Clinic100 enrolled1 locationNCT04047264
Recruiting
Phase 1Phase 2
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Lung CancerNon-small Cell Lung CancerSolid Tumor+4 more
Tango Therapeutics, Inc.191 enrolled13 locationsNCT06810544
Recruiting
Phase 2
Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
Recurrent Glioblastoma, IDH-WildtypeRecurrent GliosarcomaHigh Grade Astrocytic Tumor
Mayo Clinic54 enrolled1 locationNCT05465954
Recruiting
Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Glioblastoma
Patrick Wen, MD460 enrolled12 locationsNCT02977780
Recruiting
Not Applicable
Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
Glioblastoma, IDH-wildtypeWHO Grade 4 Glioma
Mayo Clinic116 enrolled1 locationNCT07091864
Recruiting
Phase 1Phase 2
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
GliomaGlioblastoma Multiforme
Aveta Biomics, Inc.30 enrolled2 locationsNCT06011109
Recruiting
Phase 2Phase 3
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Glioblastoma
Global Coalition for Adaptive Research1,280 enrolled62 locationsNCT03970447
Recruiting
Phase 1
ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
Glioblastoma
Mayo Clinic94 enrolled1 locationNCT05917145
Recruiting
Phase 2
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
Recurrent GlioblastomaRecurrent WHO Grade 4 Glioma
Academic and Community Cancer Research United134 enrolled3 locationsNCT06160206